Propyl acetate
Star0
Identification
- Generic Name
- Propyl acetate
- DrugBank Accession Number
- DB01670
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 102.1317
Monoisotopic: 102.068079564 - Chemical Formula
- C5H10O2
- Synonyms
- Not Available
- External IDs
- FEMA NO. 2925
- NSC-72025
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UCarboxylesterase Not Available Geobacillus stearothermophilus - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as carboxylic acid esters. These are carboxylic acid derivatives in which the carbon atom from the carbonyl group is attached to an alkyl or an aryl moiety through an oxygen atom (forming an ester group).
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- Sub Class
- Carboxylic acid derivatives
- Direct Parent
- Carboxylic acid esters
- Alternative Parents
- Monocarboxylic acids and derivatives / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
- Substituents
- Aliphatic acyclic compound / Carbonyl group / Carboxylic acid ester / Hydrocarbon derivative / Monocarboxylic acid or derivatives / Organic oxide / Organic oxygen compound / Organooxygen compound
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- acetate ester (CHEBI:40116)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 4AWM8C91G6
- CAS number
- 109-60-4
- InChI Key
- YKYONYBAUNKHLG-UHFFFAOYSA-N
- InChI
- InChI=1S/C5H10O2/c1-3-4-7-5(2)6/h3-4H2,1-2H3
- IUPAC Name
- propyl acetate
- SMILES
- CCCOC(C)=O
References
- Synthesis Reference
Shigeru Hatanaka, Masayuki Fujimoto, "METHOD FOR PRODUCING n-PROPYL ACETATE." U.S. Patent US20110065951, issued March 17, 2011.
US20110065951- General References
- Not Available
- External Links
- Human Metabolome Database
- HMDB0034237
- KEGG Compound
- C14928
- PubChem Compound
- 7997
- PubChem Substance
- 46508631
- ChemSpider
- 7706
- 1649519
- ChEBI
- 40116
- ChEMBL
- CHEMBL44857
- ZINC
- ZINC000001697403
- PDBe Ligand
- 4PA
- Wikipedia
- Propyl_acetate
- PDB Entries
- 1tqh / 2o7r
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) -93 °C PhysProp boiling point (°C) 101.5 °C PhysProp water solubility 1.89E+004 mg/L (at 20 °C) STEPHEN,H & STEPHEN,T (1963) logP 1.24 HANSCH,C ET AL. (1995) - Predicted Properties
Property Value Source Water Solubility 28.2 mg/mL ALOGPS logP 1.28 ALOGPS logP 0.8 Chemaxon logS -0.56 ALOGPS pKa (Strongest Basic) -7 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 26.3 Å2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 26.69 m3·mol-1 Chemaxon Polarizability 11.39 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9927 Blood Brain Barrier + 0.9909 Caco-2 permeable + 0.795 P-glycoprotein substrate Non-substrate 0.7453 P-glycoprotein inhibitor I Non-inhibitor 0.928 P-glycoprotein inhibitor II Non-inhibitor 0.9602 Renal organic cation transporter Non-inhibitor 0.881 CYP450 2C9 substrate Non-substrate 0.8567 CYP450 2D6 substrate Non-substrate 0.8943 CYP450 3A4 substrate Non-substrate 0.6293 CYP450 1A2 substrate Inhibitor 0.5111 CYP450 2C9 inhibitor Non-inhibitor 0.9411 CYP450 2D6 inhibitor Non-inhibitor 0.9408 CYP450 2C19 inhibitor Non-inhibitor 0.9213 CYP450 3A4 inhibitor Non-inhibitor 0.9688 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8855 Ames test Non AMES toxic 0.9363 Carcinogenicity Carcinogens 0.6093 Biodegradation Ready biodegradable 0.9703 Rat acute toxicity 1.1293 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.962 hERG inhibition (predictor II) Non-inhibitor 0.9191
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 116.5707241 predictedDarkChem Lite v0.1.0 [M-H]- 116.5775241 predictedDarkChem Lite v0.1.0 [M-H]- 116.4965241 predictedDarkChem Lite v0.1.0 [M-H]- 116.6370241 predictedDarkChem Lite v0.1.0 [M-H]- 129.1012 predictedDeepCCS 1.0 (2019) [M+H]+ 116.4566241 predictedDarkChem Lite v0.1.0 [M+H]+ 116.3093241 predictedDarkChem Lite v0.1.0 [M+H]+ 117.1859241 predictedDarkChem Lite v0.1.0 [M+H]+ 117.4003241 predictedDarkChem Lite v0.1.0 [M+H]+ 130.99661 predictedDeepCCS 1.0 (2019) [M+Na]+ 117.1396241 predictedDarkChem Lite v0.1.0 [M+Na]+ 117.0719241 predictedDarkChem Lite v0.1.0 [M+Na]+ 117.0928241 predictedDarkChem Lite v0.1.0 [M+Na]+ 117.0172241 predictedDarkChem Lite v0.1.0 [M+Na]+ 139.22714 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsCarboxylesterase
- Kind
- Protein
- Organism
- Geobacillus stearothermophilus
- Pharmacological action
- Unknown
- General Function
- Carboxylic ester hydrolase activity
- Specific Function
- Involved in the detoxification of xenobiotics. Shows maximal activity with C6 substrates, with gradually decreasing activity from C8 to C12 substrates. No activity for higher chain length substrate...
- Gene Name
- est
- Uniprot ID
- Q06174
- Uniprot Name
- Carboxylesterase
- Molecular Weight
- 28256.125 Da
References
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:51